ICFG China advises Alliance Pharma on the sale of a majority stake to Zuellig Pharma
| Seller | Alliance Pharma |
| Target | Alliance Pharma |
| Deal Type | Mergers & Acquisitions |
| Buyer | Zuellig Pharma |
| Territory | Cambodia |
| Transaction Description | CIGP is pleased to have acted as the exclusive financial advisor to the shareholders of Alliance Pharma (Cambodge) on the sale of a majority stake to Zuellig Pharma. Alliance Pharma (Cambodge) has been providing international healthcare companies with a full range of services designed to facilitate access to the Cambodian market since 2001. Over the years, Alliance Pharma (Cambodge) has developed a full-scale WHO-GSDP certified distribution infrastructure for vaccines, cold-chain products as well as pharmaceutical products, operated by approximately 400 experts in distribution and sales & marketing. CIGP advised the two main shareholders of Alliance Pharma (Cambodge), Madame Chhay Nay and Mr. Denis Florin on the disposal of a majority stake in their company, leveraging CIGP’s relevant experience in the healthcare sector as well as its presence in both Europe and Asia. |
| Industry Sector | Healthcare |
| ICFG Office | Hong Kong |
| ICFG member CIGP, based in Hong Kong, has advised the shareholders of Alliance Pharma (Cambodge), a leading healthcare and consumer health products distributor in Cambodia, on the sale of a majority stake to Zuellig Pharma, a leading healthcare services provider in Asia, headquartered in Singapore. |
